38
Growth Score in past quarter
pts
Heat Score 38 in past quarter
-40 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2668669
Clonexpress, Inc. develops patented biotech for cell therapy and drug discovery, featuring seamless DNA cloning technology.
About the Company
Clonexpress, Inc. specializes in biotechnology, focusing on the development of patient-specific cells including Beta Cells, Dopaminergic neurons, and Hepatocytes. The company has developed a patented technology for cell therapy, drug discovery, and drug metabolism applications. Clonexpress holds two issued patents (US 9029141 and 9394525) for its
innovative approaches. Its flagship products, ClonExpress II One Step Cloning Kit and ClonExpress Ultra One Step Cloning Kit, utilize seamless DNA cloning technology for efficient and directional cloning of inserted fragments. This technology is designed to support research in vitro, offering a simple, fast, and highly efficient method for DNA cloning, compatible with various reaction systems.